From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors
Comp.
%G0/G1
%S
%G2/M
%Sub-G1
Control
56.30
23.10
20.60
2.64
8u
45.32
29.11
25.57
4.40